Wall Street Analysts See a 408.63% Upside in Intellia Therapeutics (NTLA): Can the Stock Really Move This High?

Shares of Intellia Therapeutics, Inc. (NTLA) have gained 14.9% over the past four weeks to close the last trading session at $7.88, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$40.08 indicates a potential upside of 408.6%.The mean estimate comprises 25 short-term price targets with a standard deviation of $26.66. While the lowest estimate of$9 indicates a 14.2% increase fro ...